Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group

Eur J Cancer. 1994;30A(7):1043. doi: 10.1016/0959-8049(94)90155-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Resistance, Multiple
  • Epirubicin / administration & dosage
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*
  • Trifluoperazine / administration & dosage

Substances

  • Trifluoperazine
  • Epirubicin